The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
Open accessAbstract
BACKGROUND: Higher serum urate levels are associated with an increased risk of diabetic kidney disease. Lowering of the serum urate level with allopurinol may slow the decrease in the glomerular filtration rate (GFR) in persons with type 1 diabetes and early-to-moderate diabetic kidney disease. METHODS: of body-surface area, and evidence of diabetic kidney disease to receive allopurinol or placebo. The primary outcome was the baseline-adjusted GFR, as measured with iohexol, after 3 years plus a 2-month washout period. Secondary outcomes included the decrease in the iohexol-based GFR per year and the urinary albumin excretion rate after washout. Safety was also assessed. RESULTS: per year; 95% CI, -1.5 to 0.4). The mean urinary albumin excretion rate after washout was 40% (95% CI, 0 to 80) higher with allopurinol than with placebo. The frequency of serious adverse events was similar in the two groups. CONCLUSIONS: We found no evidence of clinically meaningful benefits of serum urate reduction with allopurinol on kidney outcomes among patients with type 1 diabetes and early-to-moderate diabetic kidney disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; PERL ClinicalTrials.gov number, NCT02017171.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Multiple imputation of discrete and continuous data by fully conditional specification
van Buuren, S. (2007) · Statistical Methods in Medical Research · doi:10.1177/0962280206074463 · Cited by 2,827
The prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 1,406
KDOQI clinical practice guideline for diabetes and CKD: 2012 update
(2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.005 · Cited by 1,320
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Mazzali, M., Kanellis, J., Han, L., Feng, L., Xia, Y.-Y., Chen, Q., Kang, D.-H., Gordon, K. L., Watanabe, S., Nakagawa, T., et al. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00283.2001 · Cited by 826
Renal and retinal effects of enalapril and losartan in type 1 diabetes
Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A., Strand, T., Drummond, K., Donnelly, S., Goodyer, P., Gubler, M. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808400 · Cited by 791
Self-citationIntensive diabetes therapy and glomerular filtration rate in type 1 diabetes
The DCCT/EDIC Research Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1111732 · Cited by 568
Martin, C. L., Albers, J. W., Pop-Busui, R., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2114 · Cited by 499
Self-citationEffects of Allopurinol on the Progression of Chronic Kidney Disease
Badve, S. V., Pascoe, E. M., Tiku, A., Boudville, N., Brown, F. G., Cass, A., Clarke, P., Dalbeth, N., Day, R. O., de Zoysa, J. R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915833 · Cited by 473
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels
Study, G. C. K. D., Tin, A., Study, L. C., Program, V. A. M. V., Marten, J., Halperin Kuhns, V. L., Li, Y., Wuttke, M., Kirsten, H., Sieber, K. B., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0504-x · Cited by 399
Self-citationMicroalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., & Krolewski, A. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080872 · Cited by 370
Self-citationGoicoechea, M., Garcia de Vinuesa, S., Verdalles, U., Verde, E., Macias, N., Santos, A., Pérez de Jose, A., Cedeño, S., Linares, T., & Luño, J. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.11.016 · Cited by 302
Yuan, H., Yu, C., Li, X., Sun, L., Zhu, X., Zhao, C., Zhang, Z., & Yang, Z. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2527 · Cited by 266
de Boer, I. H., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2113 · Cited by 254
Ficociello, L. H., Rosolowsky, E. T., Niewczas, M. A., Maselli, N. J., Weinberg, J. M., Aschengrau, A., Eckfeldt, J. H., Stanton, R. C., Galecki, A. T., Doria, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0227 · Cited by 218
Self-citationSerum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes
Hovind, P., Rossing, P., Tarnow, L., Johnson, R. J., & Parving, H.-H. (2009) · Diabetes · doi:10.2337/db09-0014 · Cited by 215
Self-citationMathiesen, E. R., Hommel, E., Hansen, H. P., Smidt, U. M., & Parving, H.-H. (1999) · BMJ · doi:10.1136/bmj.319.7201.24 · Cited by 192
Risk for ESRD in Type 1 Diabetes Remains High Despite Renoprotection
Rosolowsky, E. T., Skupien, J., Smiles, A. M., Niewczas, M., Roshan, B., Stanton, R., Eckfeldt, J. H., Warram, J. H., & Krolewski, A. S. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040354 · Cited by 191
Jalal, D. I., Rivard, C. J., Johnson, R. J., Maahs, D. M., McFann, K., Rewers, M., & Snell-Bergeon, J. K. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp740 · Cited by 170
Self-citationPrecision of plasma clearance of iohexol for estimation of GFR in patients with renal disease.
Gaspari, F., Perico, N., Matalone, M., Signorini, O., Azzollini, N., Mister, M., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v92310 · Cited by 161
Jordan, D. M., Choi, H. K., Verbanck, M., Topless, R., Won, H., Nadkarni, G. N., Merriman, T. R., & Do, R. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002725 · Cited by 138
Measurement of Glomerular Filtration Rate
Gaspari, F., Perico, N., & Remuzzi, G. (1973) · New England Journal of Medicine · doi:10.1056/nejm197307122890221 · Cited by 124
Costacou, T., & Orchard, T. J. (2017) · Diabetes Care · doi:10.2337/dc17-1118 · Cited by 122
Clinical Trials with Missing Data
O’Kelly, M., & Ratitch, B. (2014) · Wiley eBooks · doi:10.1002/9781118762516 · Cited by 120
Pilemann-Lyberg, S., Hansen, T. W., Tofte, N., Winther, S. A., Theilade, S., Ahluwalia, T. S., & Rossing, P. R. (2019) · Diabetes Care · doi:10.2337/dc18-2173 · Cited by 77
Self-citationUric Acid and Diabetic Nephropathy Risk
Mauer, M. S., & Doria, A. (2018) · Contributions to nephrology · doi:10.1159/000484284 · Cited by 65
Self-citationThe serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes
Ahola, A. J., Sandholm, N., Forsblom, C. M., Harjutsalo, V., Dahlström, E. H., & Groop, P. (2017) · Kidney International · doi:10.1016/j.kint.2016.11.025 · Cited by 63
Ruggenenti, P. L., Gaspari, F., Cannata, A. N., Carrara, F., Cella, C., Ferrari, S., Stucchi, N., Prandini, S., Ene‐Iordache, B., Diadei, O., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032533 · Cited by 62
The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function
Bove, M., Cicero, A. F. G., & Borghi, C. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0793-3 · Cited by 58
Afkarian, M., Polsky, S., Parsa, A., Aronson, R., Caramori, M. L., Cherney, D. Z. I., Crandall, J. P., de Boer, I. H., Elliott, T. G., Galecki, A. T., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0342 · Cited by 50
Self-citationTanamas, S. K., Saulnier, P., Fufaa, G. D., Wheelock, K. M., Weil, E. J., Hanson, R. L., Knowler, W. C., Bennett, P. H., & Nelson, R. G. (2016) · Diabetes Care · doi:10.2337/dc16-0795 · Cited by 18
(1999) · doi:10.1002/(sici)1520-7560(199901/02)15:1<65::aid-dmrr3>3.0.co;2-x
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Badve, S. V., Pascoe, E. M., Tiku, A., Boudville, N., Brown, F. G., Cass, A., Clarke, P., Dalbeth, N., Day, R. O., de Zoysa, J. R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915833 · Cited by 473
Uric acid and cardiovascular disease: A clinical review
Saito, Y., Tanaka, A., Node, K., & Kobayashi, Y. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.12.013 · Cited by 374
Metadata
- Authors
- Doria, A., Galecki, A. T., Spino, C., Pop-Busui, R., Cherney, D. Z., Lingvay, I., Parsa, A., Rossing, P., Sigal, R. J., Afkarian, M., Aronson, R., Caramori, M. L., Crandall, J. P., de Boer, I. H., Elliott, T. G., Goldfine, A. B., Haw, J. S., Hirsch, I. B., Karger, A. B., Maahs, D. M., McGill, J. B., Molitch, M. E., Perkins, B. A., Polsky, S., Pragnell, M., Robiner, W. N., Rosas, S. E., Senior, P., Tuttle, K. R., Umpierrez, G. E., Wallia, A., Weinstock, R. S., Wu, C., & Mauer, M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-06-25
- Volume
- 382
- Issue
- 26
- Pages
- 2493-2503
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3037804099
- Cited by
- 377
- References
- 40
- FWCI
- 29.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.